Open Orphan Share Discussion Threads

[mark10101] 20/1/2021 21:07

Disco, I understand perfectly well what they are, it is a good thing! From a chart point of view it is good to print that we bounced of the 30 day moving average. We will open down tomorrow first thing, then where do we go?

I 100% prefer closing where we did with a UT than below the 30 day moving average. Let’s see what tomorrow brings. Maybe people will be back to looking at a half full glass...

[discojames] 20/1/2021 20:34

Mark, it's not my view, it's fact. If you don't understand uncrossing trades, it doesn't have any effect on me nor the share price. Pretty much gaurabtee this will open "down" tomorrow as it will compare to that false closing price, in reality it will open flat without an RNS.

[orphan1] 20/1/2021 19:44

In one week things change dramatically Beep Beep

[orphan1] 20/1/2021 19:43

Beep Beep Believe the holy grail is 'said to be near'

[jimzi] 20/1/2021 19:20

As Owen says.

[mark10101] 20/1/2021 17:49

Disco, that is you view, I take it as a good sign, certainly when looking at the chunky late printed trades.

[discojames] 20/1/2021 16:59

That UT is meaningless and all it means is it will open "down" tomorrow as it will compare the price to the UT of today, when in reality it will probably just open flat, save any RNS

[owenski] 20/1/2021 16:51

Too many traders here, noisy BB full of pointless posts. would be good to see a few weaned out due to boredom.

[bearnecessities] 20/1/2021 16:37

I was gonna say. Unexpected after a dreary week so far, but I'll take it.

[1gw] 20/1/2021 16:36

Biondvax could still work well. If Seek do intend to focus on their new mRNA Covid vaccine, then they may be happy to let go of the scientific lead on FLU-v (which I assume they have had, given the new ConserV CSO's CV). So instead of Imutex contracting work to the Seek team, they could contract it to the Biondvax team if Orph reverse into BVXV, with some oversight from the ConserV CSO.

[mark10101] 20/1/2021 16:36

24.7p UT close. Things must be getting close.

[pierre oreilly] 20/1/2021 16:29

It would be a crying shame if all biondvax's expertise in a universal flu vaccine dev all just evaporated into the ether.

Surely, it must be a perfect fit for imutex's flu vaccine candidate - by whatever vehicle is used.

I was hoping imutex would reverse into it - an easy nas quote. Looks like that won't happen now if our speculation is correct.

Nas quote, isreali expertise, uni flu vaccine candidate gets closer to market, foot in another part of the world. Seems a win win win to me. I'd be very surprised if c isn't looking into this at this very moment.

[chica1] 20/1/2021 16:23

Its appears Imutex does own 49% of the proprietary
Peptide modelling platform if a Covid vaccine is developed.

From the Imutex website

hxxps://www.openorphan.com/our-businesses/imutex

'Imutex’s proprietary peptide modelling platform could have possible uses in identifying a peptide for use in a Coronavirus vaccine by using the successful FLU-v vaccine but swapping out the universal flu peptide with a peptide specific to COVID-19. Open Orphan’s management team is optimistic about the potential to monetise these assets through licensing them to Big Pharma for further development.'

[1gw] 20/1/2021 16:17

It would be good to get an update from CF on all this, but he can't realistically do that before the deal is done (sale, reverse or decision to float). I noticed the BiondVax price spiked yesterday on volume, although it has crashed back down today. I wonder if that move up was linked to speculation around the ConserV publicity.

[mark10101] 20/1/2021 16:10

As stated before our active Eeyhore John is a spoiler, he is here for a reason, all good signs to me (been topping up myself this afternoon) as they only turn up just before the fun starts.

[pierre oreilly] 20/1/2021 16:07

We could discuss 100% known facts.

Anyone want to discuss the possibility of orph reversing into hvivo?

How about discussing whether or not hvivo owns a share in imutex?

I thought investing was about speculation of the unknown, everything known being in the price sort of thing (usually!).

[m5] 20/1/2021 15:45

Fair one, LOL!!

[jimzi] 20/1/2021 15:38

Kin’ell
It’s valued at nil atm. If you don’t have faith in CF to negotiate, why are you here. It is totally pointless endlessly spouting hypothesis when you have 10% of the facts.
Whatever happens, a value will be established- that’s what we all want - even 22p misery

[1gw] 20/1/2021 15:37

The whole premise here is that the Nasdaq is hungry for opportunities to invest in vaccine-focused companies. So whether this is the float of a very focused company like Imutex, or the float of a broader portfolio company like ConserV, or a raise from an existing shell company that Orph reverses its assets into, it shouldn't make much difference (except administratively) - the money should be there.

And if the premise is right, then once on the Nasdaq in whatever form there should be investor demand for shares - which would give us (Orph investors) the chance to cash out if that's what we want to do with shares we get in a new Orph vehicle.

[1gw] 20/1/2021 15:26

Flu-V would be funded by the Imutex shareholders which in this scenario would be ConserV and the Hvivo spinco. In turn, ConserV and Spinco would raise the funds from the Nasdaq, if that's where they are floated/reversed.

[m5] 20/1/2021 15:25

Lets hope we can get some clarification from CF what the plan is here.

[john henry] 20/1/2021 15:20

1gw totally agree.

Greenelf i originally hoped that Imutex would be sold and a divi paid to shaeholders, i then hoped Imutex would be IPO ed into a separate vehicle with its own funding. Now its looking like HVIVO will be spinning out its own Vehicle, not sure that is going to work to well for shareholders.
How will Flu V phase 3 be funded ??? gets complicated.

[pogue] 20/1/2021 15:17

1gw
fair point would have worked if it was only Imutex assets going into the new company they could then offer us 49% of it, gets complicated with other bits in the new company.